Citadel Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.71M | Sell |
1,094,901
-616,074
| -36% | -$896K | ﹤0.01% | 6427 |
|
|
2025
Q4 | $1.97M | Sell |
1,710,975
-923,052
| -35% | -$1.27M | ﹤0.01% | 5950 |
|
|
2025
Q3 | $3.56M | Buy |
+2,634,027
| New | +$2.99M | ﹤0.01% | 4982 |
|
|
2025
Q2 | – | Sell |
-406
| Closed | -$263 | – | 13999 |
|
|
2025
Q1 | $187 | Sell |
406
-25,426
| -98% | -$16K | ﹤0.01% | 14311 |
|
|
2024
Q4 | $19.1K | Sell |
25,832
-72,792
| -74% | -$87.7K | ﹤0.01% | 13211 |
|
|
2024
Q3 | $155K | Sell |
98,624
-2,310,832
| -96% | -$4.12M | ﹤0.01% | 10527 |
|
|
2024
Q2 | $4.05M | Buy |
2,409,456
+2,274,979
| +1,692% | +$4.08M | ﹤0.01% | 4078 |
|
|
2024
Q1 | $323K | Sell |
134,477
-651,683
| -83% | -$1.4M | ﹤0.01% | 9292 |
|
|
2023
Q4 | $1.2M | Buy |
786,160
+784,249
| +41,039% | +$932K | ﹤0.01% | 6321 |
|
|
2023
Q3 | $2.08K | Sell |
1,911
-410,408
| -100% | -$720K | ﹤0.01% | 13763 |
|
|
2023
Q2 | $944K | Buy |
412,319
+301,490
| +272% | +$800K | ﹤0.01% | 6585 |
|
|
2023
Q1 | $269K | Sell |
110,829
-51,347
| -32% | -$118K | ﹤0.01% | 9597 |
|
|
2022
Q4 | $310K | Buy |
162,176
+34,983
| +28% | +$74.4K | ﹤0.01% | 9245 |
|
|
2022
Q3 | $306K | Sell |
127,193
-38,486
| -23% | -$107K | ﹤0.01% | 9535 |
|
|
2022
Q2 | $308K | Sell |
165,679
-286,133
| -63% | -$546K | ﹤0.01% | 9743 |
|
|
2022
Q1 | $945K | Buy |
451,812
+418,766
| +1,267% | +$1.16M | ﹤0.01% | 7835 |
|
|
2021
Q4 | $130K | Sell |
33,046
-13,810
| -29% | -$67.1K | ﹤0.01% | 12449 |
|
|
2021
Q3 | $225K | Buy |
46,856
+35,223
| +303% | +$145K | ﹤0.01% | 11729 |
|
|
2021
Q2 | $54K | Sell |
11,633
-120,859
| -91% | -$582K | ﹤0.01% | 13307 |
|
|
2021
Q1 | $778K | Buy |
+132,492
| New | +$917K | ﹤0.01% | 8707 |
|
|
2020
Q2 | – | Sell |
-73,283
| Closed | -$144K | – | 10215 |
|
|
2020
Q1 | $143K | Sell |
73,283
-245,529
| -77% | -$731K | ﹤0.01% | 8341 |
|
|
2019
Q4 | $1.32M | Buy |
318,812
+113,844
| +56% | +$438K | ﹤0.01% | 5083 |
|
|
2019
Q3 | $617K | Sell |
204,968
-337,779
| -62% | -$1.05M | ﹤0.01% | 6400 |
|
|
2019
Q2 | $3.41M | Buy |
542,747
+231,120
| +74% | +$1.38M | ﹤0.01% | 3657 |
|
|
2019
Q1 | $1.73M | Sell |
311,627
-24,195
| -7% | -$147K | ﹤0.01% | 4709 |
|
|
2018
Q4 | $2.23M | Buy |
335,822
+322,110
| +2,349% | +$2.61M | ﹤0.01% | 3980 |
|
|
2018
Q3 | $146K | Sell |
13,712
-90,307
| -87% | -$1.03M | ﹤0.01% | 8413 |
|
|
2018
Q2 | $1.25M | Sell |
104,019
-14,202
| -12% | -$145K | ﹤0.01% | 4834 |
|
|
2018
Q1 | $1.01M | Sell |
118,221
-50,953
| -30% | -$471K | ﹤0.01% | 4781 |
|
|
2017
Q4 | $1.67M | Buy |
169,174
+105,068
| +164% | +$1.09M | ﹤0.01% | 3894 |
|
|
2017
Q3 | $788K | Sell |
64,106
-46,620
| -42% | -$688K | ﹤0.01% | 4647 |
|
|
2017
Q2 | $1.82M | Buy |
+110,726
| New | +$1.71M | ﹤0.01% | 3297 |
|
|
2017
Q1 | – | Sell |
-18,570
| Closed | -$276K | – | 7793 |
|
|
2016
Q4 | $257K | Buy |
+18,570
| New | +$298K | ﹤0.01% | 5898 |
|
|
2016
Q2 | – | Sell |
-59,524
| Closed | -$711K | – | 7147 |
|
|
2016
Q1 | $711K | Buy |
59,524
+44,584
| +298% | +$467K | ﹤0.01% | 3914 |
|
|
2015
Q4 | $199K | Buy |
14,940
+10,846
| +265% | +$133K | ﹤0.01% | 5811 |
|
|
2015
Q3 | $44K | Sell |
4,094
-31,119
| -88% | -$340K | ﹤0.01% | 7665 |
|
|
2015
Q2 | $283K | Buy |
+35,213
| New | +$259K | ﹤0.01% | 5824 |
|
|
2015
Q1 | – | Sell |
-6,406
| Closed | -$41K | – | 8708 |
|
|
2014
Q4 | $41K | Sell |
6,406
-13,758
| -68% | -$111K | ﹤0.01% | 7340 |
|
|
2014
Q3 | $199K | Buy |
20,164
+3,853
| +24% | +$41.1K | ﹤0.01% | 5728 |
|
|
2014
Q2 | $184K | Buy |
16,311
+2,057
| +14% | +$22.1K | ﹤0.01% | 5659 |
|
|
2014
Q1 | $173K | Buy |
14,254
+5,998
| +73% | +$76.6K | ﹤0.01% | 5668 |
|
|
2013
Q4 | $104K | Buy |
8,256
+1,328
| +19% | +$21.1K | ﹤0.01% | 5575 |
|
|
2013
Q3 | $115K | Sell |
6,928
-61,629
| -90% | -$1.03M | ﹤0.01% | 5246 |
|
|
2013
Q2 | $1.04M | Buy |
+68,557
| New | +$1.04M | ﹤0.01% | 3154 |
|
Other funds holding LXRX
AG
SL
SC
VCM
